论文部分内容阅读
70例脑梗死患者根据是否合并糖尿病分为并糖尿病组(n=32)和单纯脑梗死组(n=38),另选择50例2型糖尿病患者为单纯糖尿病组,随访一年,并根据预后情况分为预后良好组和预后不良组。检测并比较各组间Hcy和hs-CRP水平。结果并糖尿病组Hcy、hs-CRP显著高于单纯糖尿病组和单纯脑梗死组(P<0.05),单纯糖尿病组和单纯脑梗死组Hcy、hs-CRP比较差异(P>0.05);18例预后不良组并糖尿病患者Hcy、hs-CRP显著高于预后良好组患者(P<0.05)。结论与单纯脑梗死和单纯糖尿病患者相比,并糖尿病患者Hcy、hs-CRP显著升高,且对患者的预后有一定的预示作用。
Seventy patients with cerebral infarction were divided into diabetic group (n = 32) and simple cerebral infarction group (n = 38) according to whether they had diabetes mellitus or not. Fifty patients with type 2 diabetes mellitus were selected as diabetic patients and followed up for one year. The situation is divided into a good prognosis group and a poor prognosis group. The levels of Hcy and hs-CRP in each group were detected and compared. Results Hcy and hs-CRP in diabetic group were significantly higher than those in simple diabetic group and simple cerebral infarction group (P <0.05), Hcy and hs-CRP in simple diabetic group and simple cerebral infarction group were significantly different (P> 0.05) Hcy and hs-CRP were significantly higher in patients with poor and diabetic group than those with good prognosis (P <0.05). Conclusion Compared with patients with simple cerebral infarction and simple diabetes mellitus, Hcy and hs-CRP in patients with diabetes mellitus were significantly increased, and the prognosis of patients with a certain predictor.